Effect of levetiracetam usage on serum creatine phosphokinase concentration in patients with epilepsy

Conclusion: We detected that LEV may cause increased CPK concentration or rhabdomyolysis. When treating patients with LEV, clinicians should closely monitor serum CPK level. To the best of our knowledge, this is the first study of elevated CPK concentration or rhabdomyolysis associated with LEV therapy in children.
Source: Journal of Pediatric Neurosciences - Category: Neuroscience Authors: Source Type: research